Indegene Limited IPO
Indegene is a “digital-first” commercialization company focused exclusively on the global life sciences industry.
The solutions enable biopharmaceutical, emerging biotech and medical devices companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient and modern manner.
Their portfolio of solutions cover all aspects of commercial, medical, regulatory and R&D operations of life sciences companies.
Life sciences enterprises require a talent pool with in-depth domain expertise on the journey of a drug or medical device from the research lab to the market to organise and analyse scientific and clinical data, navigate the regulatory landscape and the ethical guidelines within which the industry operates, and to develop the requisite medical content for healthcare professionals, patients, and payers.
Life sciences companies are embracing technological partners with the requisite domain expertise to aid them in this digital journey.
The Company is positioned at the intersection of healthcare and technology, The solutions span across different stages of the commercialization lifecycle of drugs and medical devices.
(i) Domain expertise in healthcare
(ii) Robust digital capabilities and in-house developed technology portfolio
(iii) Track record of establishing long-standing client relationships
(iv) Global delivery model
(v) Experienced management and motivated talent pool supported by marquee investors
(vi) Track record of creating value through acquisitions
Objects of the Indegene Limited IPO:
Indegene Limited IPO Details:
Promoters And Management:
Financials of Indegene Limited IPO:
|Particulares ( In Crore )||2022||2021||2020|
|Revenue From Operations||1,664||966||642|
|Employees Benefit Expenses||1,014||535||369|
|No. of Shares||22||22||22|
Comparison With Peers:
There is no listed peers in India.
Recommendation on Indegene Limited IPO:
To be updated once Indegene files for RHP.